Novo Nordisk created Semaglutide. Novo Nordisk is a Danish pharmaceutical company that specializes in the development and manufacture of diabetes care and weightloss products. Semaglutide is one of their newer products, and it has shown some impressive results in clinical trials for the treatment of type 2 diabetes.